Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations - Trial NCT06059079
Access comprehensive clinical trial information for NCT06059079 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital with Nanjing Medical University and is currently Completed. The study focuses on Acute Myocardial Infarction. Target enrollment is 80000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The First Affiliated Hospital with Nanjing Medical University
Timeline & Enrollment
N/A
Jan 01, 2015
May 31, 2023
Primary Outcome
Number of patients diagnosed with acute myocardial infarction
Summary
High-sensitive cardiac troponin T (hs-cTnT) is a cornerstone for diagnosing acute myocardial
 infarction (AMI). However, it is often challenging to diagnose AMI in patients with elevated
 hs-cTnT before a rise or fall of hs-cTnT can be observed. The elevations of hs-cTnT are
 caused not only by AMI, but also by other cardiac or even non-cardiac diseases. Thresholds
 above the 99th percentile have been proposed to improve the specificity and to accelerate the
 rule in of myocardial infarction. This study aimed to find a more accurate cut-off value to
 rule in AMI in patients with elevated hs-cTnT.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06059079
Non-Device Trial